135 related articles for article (PubMed ID: 12875522)
1. Differential HLA gene expression in measles vaccine seropositive and seronegative subjects: a pilot study.
Dhiman N; Bonilla RG; Jacobson RM; O'Kane D; Poland GA
Scand J Infect Dis; 2003; 35(5):332-6. PubMed ID: 12875522
[TBL] [Abstract][Full Text] [Related]
2. Extinction of the human leukocyte antigen homozygosity effect after two doses of the measles-mumps-rubella vaccine.
St Sauver JL; Dhiman N; Ovsyannikova IG; Jacobson RM; Vierkant RA; Pankratz VS; Jacobsen SJ; Poland GA
Hum Immunol; 2005 Jul; 66(7):788-98. PubMed ID: 16112026
[TBL] [Abstract][Full Text] [Related]
3. Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination.
Ovsyannikova IG; Jacobson RM; Vierkant RA; Shane Pankratz V; Jacobsen SJ; Poland GA
Vaccine; 2004 May; 22(15-16):1914-20. PubMed ID: 15121303
[TBL] [Abstract][Full Text] [Related]
4. Immune activation at effector and gene expression levels after measles vaccination in healthy individuals: a pilot study.
Dhiman N; Ovsyannikova IG; Oberg AL; Grill DE; Jacobson RM; Poland GA
Hum Immunol; 2005 Nov; 66(11):1125-36. PubMed ID: 16571413
[TBL] [Abstract][Full Text] [Related]
5. Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine.
Ovsyannikova IG; Pankratz VS; Vierkant RA; Jacobson RM; Poland GA
J Infect Dis; 2006 Mar; 193(5):655-63. PubMed ID: 16453260
[TBL] [Abstract][Full Text] [Related]
6. Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella-II vaccination.
Ovsyannikova IG; Jacobson RM; Vierkant RA; Jacobsen SJ; Pankratz VS; Poland GA
J Infect Dis; 2005 Feb; 191(4):515-9. PubMed ID: 15655774
[TBL] [Abstract][Full Text] [Related]
7. The contribution of HLA class I antigens in immune status following two doses of rubella vaccination.
Ovsyannikova IG; Jacobson RM; Vierkant RA; Jacobsen SJ; Pankratz VS; Poland GA
Hum Immunol; 2004 Dec; 65(12):1506-15. PubMed ID: 15603879
[TBL] [Abstract][Full Text] [Related]
8. Lack of association between transporter associated with antigen processing (TAP) and HLA-DM gene polymorphisms and antibody levels following measles vaccination.
Dhiman N; Ovsyannikova IG; Pinsky NA; Vierkant RA; Jacobsen SJ; Jacobson RM; Poland GA
Eur J Immunogenet; 2003 Jun; 30(3):195-200. PubMed ID: 12786997
[TBL] [Abstract][Full Text] [Related]
9. HLA homozygosity does not adversely affect measles vaccine-induced cytokine responses.
Ovsyannikova IG; Jacobson RM; Dhiman N; Vierkant RA; Pankratz VS; Poland GA
Virology; 2007 Jul; 364(1):87-94. PubMed ID: 17397893
[TBL] [Abstract][Full Text] [Related]
10. The influence of the HLA-DRB1*13 allele on measles vaccine response.
Hayney MS; Poland GA; Jacobson RM; Schaid DJ; Lipsky JJ
J Investig Med; 1996 Jun; 44(5):261-3. PubMed ID: 8763977
[TBL] [Abstract][Full Text] [Related]
11. HLA supertypes and immune responses to measles-mumps-rubella viral vaccine: findings and implications for vaccine design.
Ovsyannikova IG; Jacobson RM; Vierkant RA; Pankratz VS; Poland GA
Vaccine; 2007 Apr; 25(16):3090-100. PubMed ID: 17280755
[TBL] [Abstract][Full Text] [Related]
12. Could the MMR vaccine replace the measles vaccine at one year of age in Egypt?
Abbassy AA; Barakat SS; Abd El Fattah MM; Said ZN; El Metwally HA
East Mediterr Health J; 2009; 15(1):85-93. PubMed ID: 19469430
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
Vesikari T; Baer M; Willems P
Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
[TBL] [Abstract][Full Text] [Related]
14. Associations between human leukocyte antigen homozygosity and antibody levels to measles vaccine.
St Sauver JL; Ovsyannikova IG; Jacobson RM; Jacobsen SJ; Vierkant RA; Schaid DJ; Pankratz VS; Green EM; Poland GA
J Infect Dis; 2002 Jun; 185(11):1545-9. PubMed ID: 12023759
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
Sultana R; Rahman MM; Hassan Z; Hassan MS
Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
[TBL] [Abstract][Full Text] [Related]
16. Measles seroepidemiology among adolescents and young adults: response to revaccination.
Saffar MJ; Alraza-Amiri M; Ajami A; Baba-Mahmoodi F; Khalilian AR; Vahidshahi C; Shamsizadeh A
East Mediterr Health J; 2006 Sep; 12(5):573-81. PubMed ID: 17333796
[TBL] [Abstract][Full Text] [Related]
17. Seroconversion after measles vaccination at nine and fifteen months of age.
Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
[TBL] [Abstract][Full Text] [Related]
18. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
Lieberman JM; Williams WR; Miller JM; Black S; Shinefield H; Henderson F; Marchant CD; Werzberger A; Halperin S; Hartzel J; Klopfer S; Schödel F; Kuter BJ;
Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
[TBL] [Abstract][Full Text] [Related]
19. Correlates of lymphoproliferative responses to measles, mumps, and rubella (MMR) virus vaccines following MMR-II vaccination in healthy children.
Dhiman N; Ovsyannikova IG; Jacobson RM; Vierkant RA; Pankratz VS; Jacobsen SJ; Poland GA
Clin Immunol; 2005 May; 115(2):154-61. PubMed ID: 15885638
[TBL] [Abstract][Full Text] [Related]
20. Type III bare lymphocyte syndrome: lack of HLA class II gene expression and reduction in HLA class I gene expression.
Sabatier C; Gimenez C; Calin-Laurens V; Rabourdin-Combe C; Touraine JL
C R Acad Sci III; 1996 Sep; 319(9):789-98. PubMed ID: 8952882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
